Related Experiment Videos
The lymphomas: biologic implications of therapy and therapeutic implications of the new biology
Monographs in Pathology
|January 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.
Biochemical pharmacology·2010
Complementary, alternative, integrative, or unconventional medicine?
The oncologist·2001
Losing God.
The oncologist·2001
Caring for colleagues.
The oncologist·2001
Medical mistakes: a workshop on personal perspectives.
The oncologist·2001
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Problems and pitfalls in thyroid cytology.
Monographs in pathology·1997
Errors in cervical smears: minimizing the risk of medicolegal consequences.
Monographs in pathology·1997
Lipomatous tumors.
Monographs in pathology·1996
Vascular tumors: an update with emphasis on the diagnosis of angiosarcoma and borderline vascular neoplasms.
Monographs in pathology·1996
Immunohistochemistry in the differential diagnosis of soft tissue tumors.
Monographs in pathology·1996
Cytogenetics and molecular biology of soft tissue tumors.
Monographs in pathology·1996
A Systematic Intracranial Exposure-Response Evaluation of Brain-Penetrant Inhibitors: Informing Dose Selection for Brain Metastases.
Clinical and translational science·2026
Targeting Vascular Smooth Muscle Cell Senescence for Cardiovascular Pharmacology: Mechanisms and Therapeutic Perspectives.
Journal of cardiovascular pharmacology·2026
Insights into the degradation behaviour of tucatinib under stress conditions using liquid chromatography high resolution tandem mass spectrometry.
Analytical methods : advancing methods and applications·2026
Engineered dual RNAi prodrug for combined suppression of survival and cell cycle pathways in triple negative breast cancer treatment.
Chemical communications (Cambridge, England)·2026
Harnessing Functionalized Nano Lipid Carriers for Cardioprotection: Dual Drug Delivery in Focus for Precision Therapeutics.
Drug development and industrial pharmacy·2026